| scholarly article | Q13442814 |
| P50 | author | Jeffrey Lieberman | Q6176130 |
| Robert A. Rosenheck | Q21094933 | ||
| T. Scott Stroup | Q59149894 | ||
| Delwyn Miller | Q68577647 | ||
| P2093 | author name string | Jeffrey W Swanson | |
| Marvin S Swartz | |||
| Mark McGee | |||
| Richard Van Dorn | |||
| H Ryan Wagner | |||
| Joseph P McEvoy | |||
| Ahsan Khan | |||
| Fred Reimherr | |||
| Jose M Canive | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 164-172 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of Nervous and Mental Disease | Q598644 |
| P1476 | title | Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study | |
| P478 | volume | 194 |
| Q34012017 | A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial |
| Q37068828 | Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use |
| Q36328573 | Assessing illicit drug use among adults with schizophrenia. |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q33285122 | Comorbidity of substance abuse with other psychiatric disorders |
| Q30436445 | Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia |
| Q36420453 | Concomitant medication of psychoses in a lifetime perspective |
| Q39812565 | Criminal Justice System Involvement Among People with Schizophrenia |
| Q46857400 | Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder |
| Q30637935 | Drug and alcohol trajectories among adults with schizophrenia: data from the CATIE study |
| Q24289498 | Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings |
| Q40224374 | Interpreting and Applying the CATIE Results: With CATIE, context is key, when sorting out Phases 1, 1A, 1B, 2E, and 2T. |
| Q42762951 | Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'. |
| Q40175951 | Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia |
| Q44819773 | Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings. |
| Q64068260 | Mobile Intervention for Individuals With Psychosis, Dual Disorders, and Their Common Comorbidities: A Literature Review |
| Q33762494 | Neurocognitive functioning of individuals with schizophrenia: using and not using drugs |
| Q52300369 | Patients with nonaffective psychosis are at increased risk for heroin use disorders. |
| Q87505611 | Perils of Pragmatic Psychiatry: How We Can Do Better |
| Q38658672 | Pharmacological treatment of schizophrenia with comorbid substance use disorder. |
| Q36927085 | Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders |
| Q37388184 | Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in-patient settings |
| Q37091603 | Postmortem diagnosis and toxicological validation of illicit substance use. |
| Q34613000 | Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders |
| Q37156115 | Prevalence and impact of substance use among emerging adults with serious mental health conditions |
| Q37279671 | Professionals' perception on the management of patients with dual disorders |
| Q48049435 | Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders |
| Q33751954 | Reasons for illicit drug use in people with schizophrenia: Qualitative study |
| Q22252274 | Reasons for increased substance use in psychosis |
| Q50716139 | Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes. |
| Q34028727 | Striatal dopamine release in schizophrenia comorbid with substance dependence |
| Q24621711 | Substance abuse and schizophrenia: pharmacotherapeutic intervention |
| Q36712877 | Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders |
| Q55361377 | Substance use among outdoor treatment-seeking patients with mental illness: A case–control study from a tertiary care hospital of northern India. |
| Q36092716 | Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population |
| Q34130842 | Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry |
| Q36059843 | The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use. |
| Q45778447 | The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC). |
| Q36696097 | The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia |
| Q36995678 | Transcriptional correlates of human substance use. |
| Q40906666 | Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies |
| Q36960178 | Treatment of patients comorbid for addiction and other psychiatric disorders |
| Q45767391 | Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors |
| Q37174447 | Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis |
| Q36999794 | Understanding drug addiction: a neuropsychological perspective |
| Q33464064 | Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study |
| Q37326415 | Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review |
Search more.